vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $105.5M, roughly 1.9× CARRIAGE SERVICES INC). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs 8.3%, a 3.4% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 8.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $6.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 1.0%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

COLL vs CSV — Head-to-Head

Bigger by revenue
COLL
COLL
1.9× larger
COLL
$205.4M
$105.5M
CSV
Growing faster (revenue YoY)
COLL
COLL
+5.0% gap
COLL
12.9%
8.0%
CSV
Higher net margin
CSV
CSV
3.4% more per $
CSV
11.6%
8.3%
COLL
More free cash flow
COLL
COLL
$116.1M more FCF
COLL
$122.4M
$6.2M
CSV
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
1.0%
CSV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
CSV
CSV
Revenue
$205.4M
$105.5M
Net Profit
$17.0M
$12.3M
Gross Margin
62.5%
34.8%
Operating Margin
29.6%
23.3%
Net Margin
8.3%
11.6%
Revenue YoY
12.9%
8.0%
Net Profit YoY
35.3%
24.5%
EPS (diluted)
$0.48
$0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
CSV
CSV
Q4 25
$205.4M
$105.5M
Q3 25
$209.4M
$102.7M
Q2 25
$188.0M
$102.1M
Q1 25
$177.8M
$107.1M
Q4 24
$181.9M
$97.7M
Q3 24
$159.3M
$100.7M
Q2 24
$145.3M
$102.3M
Q1 24
$144.9M
$103.5M
Net Profit
COLL
COLL
CSV
CSV
Q4 25
$17.0M
$12.3M
Q3 25
$31.5M
$6.6M
Q2 25
$12.0M
$11.7M
Q1 25
$2.4M
$20.9M
Q4 24
$12.5M
$9.9M
Q3 24
$9.3M
$9.9M
Q2 24
$19.6M
$6.3M
Q1 24
$27.7M
$7.0M
Gross Margin
COLL
COLL
CSV
CSV
Q4 25
62.5%
34.8%
Q3 25
61.7%
35.3%
Q2 25
57.7%
35.2%
Q1 25
54.8%
35.3%
Q4 24
54.0%
34.4%
Q3 24
60.8%
35.2%
Q2 24
62.5%
36.2%
Q1 24
63.1%
36.0%
Operating Margin
COLL
COLL
CSV
CSV
Q4 25
29.6%
23.3%
Q3 25
29.7%
17.0%
Q2 25
18.7%
23.5%
Q1 25
12.2%
29.5%
Q4 24
20.9%
21.6%
Q3 24
21.9%
22.7%
Q2 24
32.7%
18.0%
Q1 24
34.1%
18.8%
Net Margin
COLL
COLL
CSV
CSV
Q4 25
8.3%
11.6%
Q3 25
15.0%
6.4%
Q2 25
6.4%
11.5%
Q1 25
1.4%
19.5%
Q4 24
6.9%
10.1%
Q3 24
5.9%
9.8%
Q2 24
13.5%
6.1%
Q1 24
19.1%
6.7%
EPS (diluted)
COLL
COLL
CSV
CSV
Q4 25
$0.48
$0.76
Q3 25
$0.84
$0.41
Q2 25
$0.34
$0.74
Q1 25
$0.07
$1.34
Q4 24
$0.36
$0.62
Q3 24
$0.27
$0.63
Q2 24
$0.52
$0.40
Q1 24
$0.71
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
CSV
CSV
Cash + ST InvestmentsLiquidity on hand
$386.7M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$254.8M
Total Assets
$1.7B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
CSV
CSV
Q4 25
$386.7M
$1.7M
Q3 25
$285.9M
$1.2M
Q2 25
$222.2M
$1.4M
Q1 25
$197.8M
$4.6M
Q4 24
$162.8M
$1.2M
Q3 24
$120.0M
$1.3M
Q2 24
$271.6M
$1.5M
Q1 24
$318.0M
$1.7M
Stockholders' Equity
COLL
COLL
CSV
CSV
Q4 25
$301.7M
$254.8M
Q3 25
$274.8M
$242.1M
Q2 25
$232.2M
$235.4M
Q1 25
$234.4M
$223.1M
Q4 24
$228.8M
$208.6M
Q3 24
$234.3M
$198.1M
Q2 24
$216.6M
$187.9M
Q1 24
$222.2M
$179.6M
Total Assets
COLL
COLL
CSV
CSV
Q4 25
$1.7B
$1.3B
Q3 25
$1.6B
$1.3B
Q2 25
$1.6B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.7B
$1.3B
Q3 24
$1.6B
$1.3B
Q2 24
$1.1B
$1.3B
Q1 24
$1.1B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
CSV
CSV
Operating Cash FlowLast quarter
$123.0M
$14.1M
Free Cash FlowOCF − Capex
$122.4M
$6.2M
FCF MarginFCF / Revenue
59.6%
5.9%
Capex IntensityCapex / Revenue
0.3%
7.5%
Cash ConversionOCF / Net Profit
7.25×
1.15×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
CSV
CSV
Q4 25
$123.0M
$14.1M
Q3 25
$78.4M
$24.7M
Q2 25
$72.4M
$8.1M
Q1 25
$55.4M
$13.8M
Q4 24
$84.6M
$9.3M
Q3 24
$-9.0M
$20.9M
Q2 24
$67.4M
$2.2M
Q1 24
$61.9M
$19.7M
Free Cash Flow
COLL
COLL
CSV
CSV
Q4 25
$122.4M
$6.2M
Q3 25
$78.3M
$18.0M
Q2 25
$72.4M
$5.2M
Q1 25
$54.6M
$10.6M
Q4 24
$84.1M
$4.9M
Q3 24
$-9.2M
$16.2M
Q2 24
$67.1M
$-1.4M
Q1 24
$61.4M
$16.2M
FCF Margin
COLL
COLL
CSV
CSV
Q4 25
59.6%
5.9%
Q3 25
37.4%
17.5%
Q2 25
38.5%
5.1%
Q1 25
30.7%
9.9%
Q4 24
46.2%
5.0%
Q3 24
-5.8%
16.1%
Q2 24
46.2%
-1.4%
Q1 24
42.3%
15.6%
Capex Intensity
COLL
COLL
CSV
CSV
Q4 25
0.3%
7.5%
Q3 25
0.1%
6.5%
Q2 25
0.0%
2.8%
Q1 25
0.4%
3.0%
Q4 24
0.3%
4.5%
Q3 24
0.2%
4.6%
Q2 24
0.2%
3.5%
Q1 24
0.4%
3.4%
Cash Conversion
COLL
COLL
CSV
CSV
Q4 25
7.25×
1.15×
Q3 25
2.49×
3.76×
Q2 25
6.05×
0.69×
Q1 25
22.92×
0.66×
Q4 24
6.75×
0.94×
Q3 24
-0.96×
2.11×
Q2 24
3.44×
0.34×
Q1 24
2.23×
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

Related Comparisons